Related Experiment Video
Updated: Jan 28, 2026

Quantifying the Antifungal Activity of Peptides Against Candida albicans
Published on: January 13, 2023
Amphibian-Derived Peptide Analog TB_KKG6K: A Powerful Drug Candidate Against Candida albicans with Anti-Biofilm
Cristina Schöpf1, Anik Geschwindt1, Magdalena Knapp2
1Institute of Molecular Biology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Abstract:
Candida albicans, a commensal and opportunistic fungal pathogen, is a major clinical concern due to its ability to cause infections ranging from mild mucosal conditions to life-threatening systemic diseases, particularly in immunocompromised patients. Its capacity to form biofilms on medical devices further complicates treatment by enhancing antifungal resistance and immune evasion. In the search for novel therapeutic strategies, the lysine-enriched amphibian-derived temporin B analog, TB_KKG6K, has emerged as a promising antifungal agent. This study demonstrates that TB_KKG6K exhibits potent fungicidal activity against planktonic C. albicans cells, with a low potential to induce adaptation or resistance. TB_KKG6K has no adverse impact on the anti-Candida efficacy of standard antifungal drugs when applied in combination, interacting additively with amphotericin B and caspofungin in a fungicidal mode of action. Additionally, TB_KKG6K effectively reduces biofilm maturation on silicone elastomers, a material commonly used in medical devices, further highlighting its therapeutic potential. These data together with our previous documentation of minimal cytotoxicity and irritation potential in human cells makes TB_KKG6K a strong candidate for combating both planktonic and biofilm-associated C. albicans infections. These findings underscore the dual efficacy of TB_KKG6K and its potential to address the challenges posed by C. albicans in clinical settings.
Insights
A novel amphibian-derived peptide, TB_KKG6K, shows strong fungicidal activity against Candida albicans. This peptide effectively combats both planktonic cells and biofilms, offering a promising new strategy for antifungal therapy.
Area of Science:
- Microbiology
- Mycology
- Infectious Diseases
Background:
- * *Candida albicans* is an opportunistic fungal pathogen causing significant clinical issues, especially in immunocompromised individuals.
- * Biofilm formation by *C. albicans* on medical devices increases antifungal resistance and complicates treatment.
- * Novel therapeutic agents are needed to combat *C. albicans* infections effectively.
Purpose of the Study:
- * To evaluate the antifungal activity of the amphibian-derived peptide TB_KKG6K against *Candida albicans*.
- * To assess the peptide's efficacy against planktonic cells and biofilms.
- * To determine its potential for combination therapy with existing antifungal drugs.
Main Methods:
- * Broth microdilution assays were used to determine the fungicidal activity of TB_KKG6K against planktonic *C. albicans*.
- * Biofilm inhibition assays were performed on silicone elastomers to evaluate TB_KKG6K's effect on biofilm maturation.
- * Combination studies were conducted with amphotericin B and caspofungin.
Main Results:
- * TB_KKG6K demonstrated potent fungicidal activity against planktonic *C. albicans* with low resistance potential.
- * The peptide effectively inhibited the maturation of *C. albicans* biofilms on silicone elastomers.
- * TB_KKG6K showed additive fungicidal interaction with amphotericin B and caspofungin, without compromising their efficacy.
Conclusions:
- * TB_KKG6K is a promising antifungal agent with potent activity against both planktonic and biofilm-associated *C. albicans*.
- * Its combination with existing antifungals enhances fungicidal action.
- * TB_KKG6K represents a potential therapeutic candidate for managing challenging *C. albicans* infections.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Peptide Bonds
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Self-Efficacy
Power
Biofilms

